BOLT — Bolt Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $12.08m
- -$5.52m
- $7.70m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Advisory: Alert wrongly tagged to Bolt Biotherapeutics withdrawn
Bolt Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bolt Biotherapeutics Q2 net loss narrows on restructuring and lower research activity
Bolt Biotherapeutics, Inc. expected to post a loss of $3.39 a share - Earnings Preview
Brief: Bolt Biotherapeutics Reports First Quarter 2026 Financial Results
Bolt Biotherapeutics Q1 revenue drops, net loss narrows
Bolt Biotherapeutics Q4 loss narrows as expenses fall
Advisory: Alert wrongly tagged to Bolt Biotherapeutics Inc withdrawn
Brief: Bolt Appoints Olta Andoni As Svp Of Legal And People To Support Platform Expansion Across Checkout, Identity, And Payments
Bolt Biotherapeutics Q3 collaboration revenue doubles
U.S. STOCKS ON THE MOVE-AMD, Occidental Petroleum, Tesla
U.S. STOCKS ON THE MOVE-AMD, Occidental Petroleum, Bolt Biotherapeutics
Bolt Biotherapeutics dips after cancer therapy trial delay
Bolt Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Bolt Biotherapeutics Inc expected to post a loss of $6.45 a share - Earnings Preview
Brief: Bolt Biotherapeutics Announces 120 Reverse Stock Split Effective June 6, 2025